Primary or post essential thrombocythemia/polycythemia vera
Showing 9976 - 10000 of >10,000
Lymphoma Non-Hodgkin Trial in Japan (Copanlisib (BAY80-6946))
Completed
- Lymphoma Non-Hodgkin
- Copanlisib (BAY80-6946)
-
Nagoya, Aichi, Japan
- +12 more
Feb 21, 2022
Dementia, Med: Dementia Trial in Seattle (Value Champion Training Program, No Intervention)
Not yet recruiting
- Dementia
- Med: Dementia
- Value Champion Training Program
- No Intervention
-
Seattle, WashingtonKaiser Permanente Washington Health Research Institute
Oct 25, 2022
Multiple Sclerosis (MS) Trial in Birmingham (Physical activity behavioral intervention in persons newly diagnosed with MS)
Recruiting
- Multiple Sclerosis (MS)
- Physical activity behavioral intervention in persons newly diagnosed with MS
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jan 24, 2023
Post-Traumatic Stress Disorder in Children, Post-Traumatic Stress Disorder in Adolescence Trial in Cincinnati, Houston, Salt
Recruiting
- Post-Traumatic Stress Disorder in Children
- Post-Traumatic Stress Disorder in Adolescence
- RESET
-
Cincinnati, Ohio
- +2 more
Mar 24, 2022
Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal
Recruiting
- Platinum-Resistant Fallopian Tube Carcinoma
- +8 more
- Durvalumab
- Tremelimumab
-
Houston, TexasM D Anderson Cancer Center
Jul 19, 2022
Hand, Foot and Mouth Disease Trial in Jingzhou, Xiantao (5000 volunteers (6-35 months)-EV71 vaccine)
Completed
- Hand, Foot and Mouth Disease
- 5000 volunteers (6-35 months)-EV71 vaccine
-
Jingzhou, Hubei, China
- +1 more
Jul 26, 2021
Recurrent High-grade Glioma, Recurrent Glioblastoma, Recurrent Anaplastic Astrocytoma Trial in Incheon (500mg/kg/3hr followed by
Recruiting
- Recurrent High-grade Glioma
- +3 more
- 500mg/kg/3hr followed by neutron irradiation to reach maximum brain dose of 9Gy-Eq
- +2 more
-
Incheon, Korea, Republic ofGachon University Gil Medical Center
Feb 19, 2023
Ischemic Stroke, Acute, Ischemia-reperfusion Injury, Cerebral Edema Trial in Dongguan, Guangzhou (enzyme-linked immunosorbent
Recruiting
- Ischemic Stroke, Acute
- +2 more
- enzyme-linked immunosorbent assay(ELISA)
-
Dongguan, Guangdong, China
- +1 more
Oct 15, 2022
Intrauterine Growth Restriction in Pre-eclamptic Women
Not yet recruiting
- alpha1 Anti-trypsin
- +2 more
- Alpha1 -Antitrypsin level
- (no location specified)
Nov 18, 2022
Obese, Overweight Trial in Lasalle, London (Release)
Recruiting
- Obese
- Overweight
- Release
-
Lasalle, Ontario, Canada
- +1 more
Apr 25, 2023
Adaptation and Implementation of Peer Support in Brazil
Not yet recruiting
- Peer Support
-
New Haven, ConnecticutYale University Program for Recovery and Community Health
May 1, 2023
Hand Injuries Trial (ReHeal glove with Negative Pressure Wound Therapy (NPWT))
Not yet recruiting
- Hand Injuries
- ReHeal glove with Negative Pressure Wound Therapy (NPWT)
- (no location specified)
May 3, 2023
Cardiac Rehabilitation, Acute Coronary Syndrome, Heart Failure Trial (Connected application)
Not yet recruiting
- Cardiac Rehabilitation
- +2 more
- Connected application
- (no location specified)
Dec 2, 2022
Psychomotor Disadaptation Syndrome, Post-fall Syndrome Trial in Strasbourg (rehabilitation with muscle strengthening + Oral
Not yet recruiting
- Psychomotor Disadaptation Syndrome
- Post-fall Syndrome
- rehabilitation with muscle strengthening + Oral Nutritional Supplements
- rehabilitation with muscle strengthening
-
Strasbourg, FranceService de Gériatrie aigue - CHU de Strasbourg - France
Dec 9, 2022
Stress Trial in Gustavsberg (Care manager intervention (nurse), CBT)
Recruiting
- Stress
- Care manager intervention (nurse)
- CBT
-
Gustavsberg, Stockholm, SwedenGustavsbergs Primary Care Center
May 19, 2022
Acute Respiratory Distress Syndrome Trial in Wuhan (APRV, LTV)
Recruiting
- Acute Respiratory Distress Syndrome
- APRV
- LTV
-
Wuhan, Hubei, ChinaUnion Hospital, Tongji Medical College, Huazhong University of S
Mar 1, 2023
Dystrophic Epidermolysis Bullosa, Recessive Dystrophic Epidermolysis Bullosa, Dominant Dystrophic Epidermolysis Bullosa Trial in
Completed
- Dystrophic Epidermolysis Bullosa
- +2 more
- Topical Beremagene Geperpavec
- Placebo
-
Rancho Santa Margarita, California
- +2 more
Aug 1, 2022
Age-Related Macular Degeneration Trial (Loteprednol Etabonate Ophthalmic Gel [Lotemax], Nepafenac Ophthalmic 0.3% Ophthalmic
Not yet recruiting
- Age-Related Macular Degeneration
- Loteprednol Etabonate Ophthalmic Gel [Lotemax]
- +2 more
- (no location specified)
Sep 14, 2022
Collective Outcome Measure(s) Status Post Total Hip/Knee
Completed
- Joint Arthroplasty
- Knee and Hip
-
Jacksonville, FloridaMayo Clinic in Florida
Jan 13, 2023
Prevention of SARS-CoV-2 Secondary Infection Trial in San Diego (COVID Prevention Program (CPP))
Recruiting
- Prevention of SARS-CoV-2 Secondary Infection
- COVID Prevention Program (CPP)
-
San Diego, CaliforniaSan Diego State University Research Foundation
Jan 20, 2023
Obesity Trial in Loma Linda (Semaglutide, Orlistat, Phentermine/Topiramate)
Recruiting
- Obesity
- Semaglutide
- +4 more
-
Loma Linda, CaliforniaNovo Nordisk Investigational Site
Jan 24, 2023
Metastatic Colorectal Cancer Trial in Los Angeles, Newark, Plantation (Selinexor, Pembrolizumab, Trifluridine)
Terminated
- Metastatic Colorectal Cancer
- Selinexor
- +3 more
-
Los Angeles, California
- +2 more
Jan 24, 2023
Gynecologic Disease Trial in Seongnam (Opioid-free anesthesia, Opioid-using anesthesia)
Recruiting
- Gynecologic Disease
- Opioid-free anesthesia
- Opioid-using anesthesia
-
Seongnam, Gyeonggi, Korea, Republic ofSeoul National Univ. Bundang Hospital
Jul 1, 2022